heartlinx Medical News

Cardiology

Become a Member Today!

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Cardiology

Messages

Conferences

Jobs

Newsletters

My Library

Topics in
Cardiology

Arrhythmias/EP

Atherosclerosis/Lipids

Basic Science/Genetics

Cardiac Surgery

Clinical Pharmacology

Complementary Medicine

Congenital

Coronary Artery Disease

Diagnostics

Economics of Medicine

Epidemiology

Heart Failure

Hypertension

Interventional

Myocardium/Pericardium

Pediatric Cardiology

Physiology

Popular Press

Preventive

Primary Care

Transplant/Augmentation

Valvular Disease

Vascular Medicine

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design
Cardiovascular Drugs and Therapy, 06/20/08

Email This Article

Save in My Library

Free Abstract

Valgimigli M et al. - The results of 3T/2R study will evaluate whether tailored intensification of anti-platelet treatment based on poor individual response to oral anti-platelet agents may modulate the risk of periprocedural myocardial infarction during PCI.

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor